Epsilon Healthcare Limited (EPN.AX)
ASX · AUD · Healthcare · Drug Manufacturers - Specialty & Generic
A$0.021 (+0.00%) as of
Key statistics
- Market cap
- 8.17M
- EPS (TTM)
- 0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0190 – 0.0400
- Beta
- 0.63
- Revenue (TTM)
- 13.58M
- Profit margin
- 0.47%
- Volume
- 28.32k
About Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Southport, QLD, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.